Novel Assay Discriminates Several Aspergillus Species
By LabMedica International staff writers Posted on 12 Apr 2017 |
Image: The AsperGenius is a multiplex real-time PCR assay which rapidly diagnoses Aspergillus infections and simultaneously identifies multi-azole resistance (Photo courtesy of PathoNostics).
Invasive aspergillosis (IA) is mainly caused by Aspergillus fumigatus and when diagnosis is made early and first line therapy with voriconazole is initiated promptly, a relatively low mortality is observed.
However, over the past decade, azole resistance has emerged worldwide and poses a threat as IA with azole-resistant A. fumigatus is associated with high mortality of 88%. As in vitro drug susceptibility testing is often not feasible, as cultures remain negative or sibling species fail to sporulate, molecular techniques are an option.
Scientists at the Erasmus University Medical Center used a multiplex real-time polymerase chain reaction (PCR) assay to detect Aspergillus species and mutations in the Cyp51A gene of A. fumigatus. They performed the assay on cultured sibling strains obtained from two clinical cases. In addition to assess the precision of the assay, a larger set of strains was tested: six A. lentulus strains and 12 A. felis species complex strains (five A. felis, four A. parafelis and three A. pseudofelis) were obtained and the three control A. fumigatus strains (one WT, one TR34/L98H mutant, one TR46/T289A/Y121F mutant).
The AsperGenius multiplex real-time PCR assay was performed on strains obtained from lung biopsy in one case and from pleural mass biopsy the second case. Both strains gave positive signals for the Aspergillus species and Aspergillus section Fumigati. The AsperGenius resistance PCR did not detect the TR34 target in A. lentulus and A. felis in contrast to A. fumigatus. Melting peaks for L98H and Y121F markers differed and those of the Y121F marker were particularly suitable to discriminate the three species. The authors concluded that the assay can be used to rapidly discriminate A. fumigatus, A. lentulus and A. felis. The study was published in the March 2017 issue of the journal Diagnostic Microbiology and Infectious Disease.
However, over the past decade, azole resistance has emerged worldwide and poses a threat as IA with azole-resistant A. fumigatus is associated with high mortality of 88%. As in vitro drug susceptibility testing is often not feasible, as cultures remain negative or sibling species fail to sporulate, molecular techniques are an option.
Scientists at the Erasmus University Medical Center used a multiplex real-time polymerase chain reaction (PCR) assay to detect Aspergillus species and mutations in the Cyp51A gene of A. fumigatus. They performed the assay on cultured sibling strains obtained from two clinical cases. In addition to assess the precision of the assay, a larger set of strains was tested: six A. lentulus strains and 12 A. felis species complex strains (five A. felis, four A. parafelis and three A. pseudofelis) were obtained and the three control A. fumigatus strains (one WT, one TR34/L98H mutant, one TR46/T289A/Y121F mutant).
The AsperGenius multiplex real-time PCR assay was performed on strains obtained from lung biopsy in one case and from pleural mass biopsy the second case. Both strains gave positive signals for the Aspergillus species and Aspergillus section Fumigati. The AsperGenius resistance PCR did not detect the TR34 target in A. lentulus and A. felis in contrast to A. fumigatus. Melting peaks for L98H and Y121F markers differed and those of the Y121F marker were particularly suitable to discriminate the three species. The authors concluded that the assay can be used to rapidly discriminate A. fumigatus, A. lentulus and A. felis. The study was published in the March 2017 issue of the journal Diagnostic Microbiology and Infectious Disease.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans